• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对每日20毫克氟西汀治疗无效的门诊抑郁症患者增效治疗或增加剂量反应的临床及社会人口学预测因素

Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.

作者信息

Perlis R H, Alpert J, Nierenberg A A, Mischoulon D, Yeung A, Rosenbaum J F, Fava M

机构信息

Depression Clinical and Research Program, Massachusetts General Hospital, WACC 812, 15 Parkman Street, Boston, MA 02114, USA.

出版信息

Acta Psychiatr Scand. 2003 Dec;108(6):432-8. doi: 10.1046/j.0001-690x.2003.00168.x.

DOI:10.1046/j.0001-690x.2003.00168.x
PMID:14616224
Abstract

OBJECTIVE

Patients with major depressive disorder often show only partial or no response to antidepressants, necessitating next-step interventions such as dose increase or augmentation. Factors moderating response to these next-step interventions are not well-studied.

METHOD

In this randomized, double-blind investigation of next-step treatments in 101 outpatients who failed to respond to fluoxetine 20 mg for 8 weeks, the impact of depressive course and sociodemographic factors on likelihood of treatment response following dose increase or lithium or desipramine augmentation was examined.

RESULTS

After controlling for depression severity at baseline, current marriage and earlier onset of depression were associated with greater likelihood of response in a logistic regression. Intervention strategy was not predictive of response.

CONCLUSION

Marital status and earlier onset of depression may be clinically useful in predicting outcome following any next-step intervention for treatment resistance, rather than with particular strategies.

摘要

目的

重度抑郁症患者通常对抗抑郁药仅表现出部分反应或无反应,因此需要采取下一步干预措施,如增加剂量或联合用药。对这些下一步干预措施反应的调节因素尚未得到充分研究。

方法

在这项针对101名对20毫克氟西汀治疗8周无反应的门诊患者进行的下一步治疗的随机双盲研究中,研究了抑郁病程和社会人口学因素对增加剂量或加用锂盐或去甲丙咪嗪后治疗反应可能性的影响。

结果

在控制基线抑郁严重程度后,当前婚姻状况和较早的抑郁发作在逻辑回归中与更大的反应可能性相关。干预策略不能预测反应。

结论

婚姻状况和较早的抑郁发作在临床上可能有助于预测对治疗抵抗的任何下一步干预后的结果,而不是特定的策略。

相似文献

1
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.对每日20毫克氟西汀治疗无效的门诊抑郁症患者增效治疗或增加剂量反应的临床及社会人口学预测因素
Acta Psychiatr Scand. 2003 Dec;108(6):432-8. doi: 10.1046/j.0001-690x.2003.00168.x.
2
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.重度抑郁症患者的血清叶酸、维生素B12和同型半胱氨酸,第1部分:氟西汀抵抗性抑郁症临床反应的预测因素
J Clin Psychiatry. 2004 Aug;65(8):1090-5. doi: 10.4088/jcp.v65n0810.
3
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.合并内科疾病对难治性抑郁症门诊患者氟西汀增效或增加剂量反应的影响。
Psychosomatics. 2004 May-Jun;45(3):224-9. doi: 10.1176/appi.psy.45.3.224.
4
Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.锂盐及三环类药物增强氟西汀治疗难治性重度抑郁症:一项双盲对照研究。
Am J Psychiatry. 1994 Sep;151(9):1372-4. doi: 10.1176/ajp.151.9.1372.
5
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.高剂量氟西汀与锂盐或去甲丙咪嗪增强氟西汀作用对比的双盲研究:针对氟西汀部分反应者和无反应者
J Clin Psychopharmacol. 2002 Aug;22(4):379-87. doi: 10.1097/00004714-200208000-00008.
6
Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.联合去甲肾上腺素和5-羟色胺再摄取抑制机制治疗抑郁症:一项双盲随机研究。
Biol Psychiatry. 2004 Feb 1;55(3):296-300. doi: 10.1016/j.biopsych.2003.08.007.
7
Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?那些对氟西汀和三环类抗抑郁药均无反应的抑郁症患者对这两种药物的联合使用会有反应吗?
J Clin Psychiatry. 1999 Sep;60(9):613-6. doi: 10.4088/jcp.v60n0908.
8
Augmentation strategies with serotonergic-noradrenergic combinations.5-羟色胺能与去甲肾上腺素能联合增强策略。
J Clin Psychiatry. 1998;59 Suppl 5:65-8; discussion 69.
9
Comparison of TCAs and SSRIs in the treatment of major depression in hospitalized geriatric patients.三环类抗抑郁药与选择性5-羟色胺再摄取抑制剂治疗老年住院患者重度抑郁症的比较
J Geriatr Psychiatry Neurol. 1995 Jul;8(3):173-6. doi: 10.1177/089198879500800306.
10
An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.一项关于丁螺环酮增强5-羟色胺再摄取抑制剂治疗难治性抑郁症的开放性研究。
J Clin Psychiatry. 1993 Jul;54(7):269-71.

引用本文的文献

1
What predicts response to sertraline for people with depression in primary care? a secondary data analysis of moderators in the PANDA trial.什么因素可以预测在初级保健中接受舍曲林治疗的抑郁症患者的反应?PANDA 试验中调节因素的二次数据分析。
PLoS One. 2024 May 9;19(5):e0300366. doi: 10.1371/journal.pone.0300366. eCollection 2024.
2
Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study.西酞普兰增强了生活条件对参与STAR*D研究的抑郁症患者情绪的影响。
Transl Psychiatry. 2017 Mar 21;7(3):e1066. doi: 10.1038/tp.2017.35.
3
Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients.
抑郁症患者及抗抑郁治疗抵抗患者对帕罗西汀诱导的外周血单核细胞生长抑制的敏感性降低。
Transl Psychiatry. 2016 May 31;6(5):e827. doi: 10.1038/tp.2016.90.
4
A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.对谷氨酸能-单胺能相互作用的分子通路分析有助于研究西酞普兰治疗期间的抑郁记录数量。
J Neural Transm (Vienna). 2015 Mar;122(3):465-75. doi: 10.1007/s00702-014-1267-2. Epub 2014 Jul 2.
5
Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison.运动作为未缓解的重度抑郁症的增强治疗:一项随机、平行剂量比较。
J Clin Psychiatry. 2011 May;72(5):677-84. doi: 10.4088/JCP.10m06743.
6
Pharmacogenetics in psychiatry: are we ready for widespread clinical use?精神病学中的药物遗传学:我们准备好广泛应用于临床了吗?
Schizophr Bull. 2008 Nov;34(6):1130-44. doi: 10.1093/schbul/sbn114. Epub 2008 Aug 27.
7
Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases.剖析抑郁症预后的决定因素:对两个临床病例的深入分析。
Ann Gen Psychiatry. 2007 Feb 7;6:5. doi: 10.1186/1744-859X-6-5.
8
Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.医学共病对重度抑郁症抗抑郁治疗的影响。
Curr Psychiatry Rep. 2004 Jun;6(3):193-201. doi: 10.1007/s11920-004-0064-2.